Skip to main content
. 2013 Sep 11;53:72–84. doi: 10.1111/head.12186

Fig 6.

Fig 6

Pharmacokinetics (PK) profiles for nasal sumatriptan from two crossover studies performed with the Breath Powered powder device and the marketed Imitrex sumatriptan nasal spray. The one study was done in migraine patients during GTN-challenge, whereas the other study was performed in healthy volunteers.